Jefferies Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-16,900
Closed -$195K 2587
2017
Q4
$195K Hold
16,900
﹤0.01% 2229
2017
Q3
$321K Hold
16,900
﹤0.01% 1849
2017
Q2
$407K Hold
16,900
﹤0.01% 1705
2017
Q1
$335K Sell
16,900
-10,242
-38% -$229K ﹤0.01% 1770
2016
Q4
$654K Sell
27,142
-116,338
-81% -$3.24M ﹤0.01% 1482
2016
Q3
$3.98M Sell
143,480
-498,345
-78% -$13.2M 0.02% 620
2016
Q2
$15.7M Buy
641,825
+291,702
+83% +$8.28M 0.07% 173
2016
Q1
$11.8M Buy
350,123
+340,033
+3,370% +$10.7M 0.07% 218
2015
Q4
$302K Buy
10,090
+2,623
+35% +$88.4K ﹤0.01% 1780
2015
Q3
$235K Buy
+7,467
New +$364K ﹤0.01% 1873

Other funds holding PGEN

Jefferies Group's PGEN Position: Q3 2019 in Review

Jefferies Group sold out of Precigen (PGEN) in Q3 2019, closing a stake of 25,700 shares — an estimated $197K sold.

Jefferies Group first reported a position in PGEN in Q4 2014 and held it in 13 quarters. The position peaked at $2.78M in Q4 2014. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • Jefferies Group reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 25,700 Precigen shares in Q3 2019, an estimated $197K.
  • Jefferies Group first reported a position in Precigen in Q4 2014 and held it in 13 quarters.
  • Jefferies Group's Precigen position peaked at $2.78M in Q4 2014.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.